mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |